Listen "Merck’s new COVID-19 pill will save lives, but at what price?"
Episode Synopsis
Joseph Allen, executive director of the Bayh-Dole Coalition, explains how molnupiravir, from Ridgeback Biotherapeutics, and partner Merck & Co. Inc., may have never had a chance to move out of the university onto pharmacy shelves without the government’s support. Hosted on Acast. See acast.com/privacy for more information.